Rifampicin-loaded liposomes for the passive targeting to alveolar macrophages: In vitro and in vivo evaluation

Journal of Liposome Research

Volumn 19, Issue 1, 2009, Pages 68-76

  Zaru, Marco ^a   Sinico, Chiara ^a   De Logu, Alessandro ^a   Caddeo, Carla ^a   Lai, Francesco ^a   Manca, Maria Letizia ^a   Fadda, Anna Maria ^a  

^a UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Aerosol delivery; Liposomes; MAC; Macrophages; Nebulization; Rifampicin

Indexed keywords

CHOLESTEROL; LIPOSOME; PHOSPHATIDYLCHOLINE; RIFAMPICIN; TUBERCULOSTATIC AGENT;

AEROSOL; ANIMAL CELL; ANIMAL CELL CULTURE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBACTERIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG STABILITY; DRUG TISSUE LEVEL; ENCAPSULATION; FILM; IN VITRO STUDY; IN VIVO STUDY; LUNG ALVEOLUS MACROPHAGE; MALE; MOUSE; MYCOBACTERIUM INTRACELLULARE AVIUM; NEBULIZATION; NEBULIZER; NONHUMAN; PHOSPHOLIPID VESICLE; PRIORITY JOURNAL; RAT; VISCOSITY; ANIMAL; ATYPICAL MYCOBACTERIOSIS; CELL LINE; CHEMISTRY; HUMAN; MICROBIOLOGY; WISTAR RAT;

ANIMALS; ANTIBIOTICS, ANTITUBERCULAR; CELL LINE; CHOLESTEROL; HUMANS; LIPOSOMES; MACROPHAGES, ALVEOLAR; MALE; MICE; MYCOBACTERIUM AVIUM COMPLEX; MYCOBACTERIUM AVIUM-INTRACELLULARE INFECTION; PHOSPHATIDYLCHOLINES; RATS; RATS, WISTAR; RIFAMPIN;

EID: 70349571738     PISSN: 08982104     EISSN: 15322394     Source Type: Journal    
DOI: 10.1080/08982100802610835     Document Type: Article

References (32)

1. Corti M, Palmero D (2008). Mycobacterium avium complex infection in HIV/AIDS patients. Exp Rev Anti Infect Ther 6, 351-363.
2. Inderlied CB, Kemper CA, Bermudez LEM (1993). The Mycobacterium avium complex. Clin Microbiol Rev 6, 266-310.
3. Peloquin CA. (1997) Mycobacterium avium complex infection. Clin Pharmacokinet 32, 132-144.
4. Kobashi Y, Matsushima T. (2003). The effect of combined therapy according to the guidelines for the treatment of Mycobacterium avium complex pulmonary disease. Intern Med 42, 670-675. (Pubitemid 37021197)
5. Tomioka H, Sano C, et al. (2002). Antimicrobial activities of clarithromycin, gatiofloxacin and sitafloxacin, in combination with various antimycobacterial drugs against extracellular and intramacrophage Mycobacterium avium complex. Int J Antimicrob 19, 139-145.
6. Brisseau GF, Kresta A, et al. (1994). Unilamellar liposomes modulate secretion of tumor necrosis factor by lipopolysaccharidestimulated macrophages. Antimicrob Agents Chemother 38, 2671-2675.
7. Onyeji CO, Nightingale CH, Marangos MN (1994). Enhanced killing of methicillin-resistant Staphylococcus aureus in human macrophages by liposome-entrapped vancomycin and teicoplanin. Infection 22, 338-342.
8. Oh Y-K, Nix DE, Straubinger RM (1995). Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection. Antimicrob Agents Chemother 39, 2104-2111.
9. Gupta CM, Haq W (2005). Tuftsin-bearing liposomes as antibiotic carriers in treatment of macrophage infections. Methods Enzymol 391, 291-304.
10. Samad A, Sultana Y, Aqil M (2007). Liposomal drug delivery systems: an update review. Curr Drug Deliv 4, 297-305.
11. Weaver T, Hall CL, et al. (1996). Assessment of in vivo attachment/ phagocytosis by alveolar macrophages. J Immunol Methods 193, 149-156.
12. Bridges PA, Taylor KMG (1998). Nebulisers for the generation of liposomal aerosols. Int J Pharm 173, 117-125.
13. Desai TR, Hancock REW, Finlay WH (2002). A facile method of delivery of liposomes by nebulization. J Control Release 84, 69-78.
14. Vyas SP, Kannan ME (2004). Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages. Int J Pharm 269, 37-49.
15. Bridges PA, Taylor KMG (2000). An investigation of some of the factors influencing the jet nebulisation of liposomes. Int J Pharm 204, 69-79.
16. Elhissi AMA, Kiran K, et al. (2006). Formulations generated from ethanol- based proliposomes for delivery via medical nebulizers. J Pharm Pharmacol 58, 887-894.
17. Bermudez M, Martinez E, et al. (1999). Molecular and physicochemical aspects of the interactions of the tuberculostatics ofloxacin and rifampicin with liposomal bilayers: a 31P-NMR and DSC study. Colloids Surf A 158, 59-66.
18. Rodrigues C, Gamiero P, Reis , et al. (2001). Derivative spectrophotometry as a tool for the determination of drug partition coeffi - cients in watwr/dimyristoyl-L-α-phosphatidylglycerol (DMPG) liposomes. Biophys Chem 94, 97-106.
19. Rodrigues C, Gamiero P, et al. (2003). Interaction of rifampicin and isoniazid with large unilamellar liposomes: spectroscopic location studies. Biochim Biophys Acta 1620, 151-159.
20. Zaru M, Mourtas S, et al. (2007). Liposomes for drug delivery to the lungs by nebulization. Eur J Pharm Biopharm 67, 655-666.
21. Bangham AD, Standish MM, Watkins JC (1965). Diffusion of univalent ions across the lamellae of swollen phospholipids. J Mol Biol 13, 238-252.
22. Waldrep JC, Arppe J, et al. (1998). Experimental pulmonary delivery of cyclosporine A by liposome aerosol. Int J Pharm 160, 239-249.
23. Kumar AKH, Chandra I, et al. (2004). A validated high-performance liquid chromatography method for the determination of rifampicin and desacetyl rifampicin in plasma and urine. Indian J Pharmacol 36, 231-233.
24. Darwis Y, Kellaway IW (2001). Nebulization of rehydrated freezedried beclomethasone dipropionate liposomes. Int J Pharm 215, 113-121.
25. Bhavane R, Karathanasis E, Ananth V (2003). Agglomerated vesicle technology: a new class of particles for controlled and modulated pulmonary drug delivery. J Control Release 93, 15-28.
26. Suarez S, Kazantseva M (2001). The influence of suspension nebulization or instillation on particulate uptake by guinea pig alveolar macrophages. Inhal Toxicol 13, 773-788.
27. Desai TR, Tyrrel GJ, et al. (2003). In vitro evaluation of nebulization properties, antimicrobial activity, and regional airways surface liquid concentration of liposomal polymyxin B sulfate. Pharm Res 20, 442-447.
28. Lange FC, Hancock REW, et al. (2001). In vitro aerosol delivery and regional airway surface liquid concentration of a liposomal cationic peptide. J Pharm Sci 90, 1647-1657.
29. Pavelic Z, Skalko-Basnet N, et al. (2005). Development and in vitro evaluation of a liposomal vaginal delivery system for acyclovir. J Control Release 106, 34-43.
30. Sweeney LG, Wang Z, et al. (2005). Spray-freeze-dried liposomal ciprofloxacin powder for inhaled aerosol drug delivery. Int J Pharm 305, 180-185.
31. Terzano C, Allegra L, et al. (2005). Non-phospholipid vesicles for pulmonary glucocorticoid delivery. Eur J Pharm Biopharm 59, 57-62.
32. O'Callaghan C, White J, et al. (2002). The output of flunisolide from different nebulisers. J Pharm Pharmacol 54, 565-569.